severity

October 16, 2018

Triple Therapy Improves COPD Exacerbations Regardless of Reversibility Status

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) continues to boast positive findings from the Informing the Pathway of COPD Treatment (IMPACT) study. In new data to be presented at the 2018 CHEST Annual Meeting in San Antonio, TX, GlaxoSmithKline (GSK) has reported their first-of-its-kind triple therapy inhaler significantly reduced the annual rate of moderate-to-severe…

August 18, 2018

Research Suggests New Mechanism at Play in Some Severe Asthma Cases

A newly published study offers a better understanding of the mechanisms at play in a subset of patients with severe asthma. Scientists hope the new insights will help direct the development of more tailored approaches to asthma therapy. For the study, a team of investigators from several US academic research hospitals set out to better…